Nocardithiocin is a novel thiopeptide compound produced by the pathogenic Nocardia pseudobrasiliensis strain IFM 0757. It shows a strong activity against acid-fast bacilli such as the Mycobacterium and Gordonia species. Nocardithiocin was highly active against rifampicin-resistant as well as -sensitive Mycobacterium tuberculosis strains, and most of the resistant strains were inhibited at concentrations ranging from 0.025 to 1.56 lg ml À1 . The structure of the thiopeptide antibiotic containing thiazole, natural and unnatural amino acids was elucidated by MS and NMR spectral analyses.
INTRODUCTION
Actinomycetes produce numerous secondary metabolites including various biologically active compounds such as antimicrobial, cytotoxic, immunosuppressive and antifungal agents. 1 As the potential to isolate useful new antibiotics from Streptomyces sp. is now low and diminishing all the time, we have focused our attention on other sources. Pathogenic actinomycetes are distributed on a limited basis in the natural environment and are difficult to isolate. They can be considered among the rare actinomycetes and represent a relatively unexplored resource for the discovery of new bioactive compounds. We have collected many pathogenic actinomycetes from clinical materials, which mainly belong to the genus of Nocardia and may cause human infections called nocardiosis. 2, 3 They have produced several biologically active compounds such as antitumor and immunosuppressive ones. 4, 5 During our ongoing research for new metabolites from a Nocardia strain (IFM 0757 strain) obtained from a patient at the Health Center, University of Texas, we isolated a new cyclic thiopeptide antibiotic with potent antibacterial activity against rifampicin-resistant Mycobacterium tuberculosis, called nocardithiocin (Figure 1 ), which was classified as a 'series d' group peptide antibiotic based on the definition by Bagley et al. 6 Cyclic thiopeptides are known as activators of thiostrepton-induced protein A, which is a member of the mercury resistance regulator family, and are active against Gram-positive bacteria. 3, 7 In this paper, we describe the fermentation, isolation, structure elucidation and antimicrobial activities of the antibiotic.
RESULTS

Isolation
The separation of the active compounds was monitored by the antimicrobial activity against Corynebacterium xerosis IFM 2057. 8 After incubation, the culture broth was centrifuged at 3000 r.p.m. for 10 min. Six hundred milliliters of MeOH was then added to the mycelial cake and stirred for 3 hours. The MeOH fraction was filtered, evaporated to dryness and suspended in distilled water. The active compound was then extracted with EtOAc. The compound was further purified by HPLC. The isolation was carried out under dark conditions because the antibiotic was not stable in the light.
Structure elucidation
The physicochemical data for nocardithiocin are shown in Table 1 . The positive ion FAB mass spectrum (JMS-AX500) of nocardithiocin showed a protonated molecule [M+H] + at m/z 1161. HRFAB-MS (JMS-HX110) displayed the [M+K] + ion at m/z 1199.1469 (calcd. 1199.1527). The molecular formula was determined to be C 48 H 48 N 12 O 11 S 6 based on the HRFAB-MS data by considering the number of protons and carbons from the NMR spectra. In the 1 H-NMR spectrum, one singlet and four doublet signals assigned to five methyl groups were observed between d 0.86-1.78, and two singlet signals (d 3.70 and 3.97) were assigned to methoxyl groups. Amino acid moiety a-proton signals were also observed at d 4.52 (H-46), 5.11 (H-32) and 5.56 (H-22). Thirteen sp 2 proton signals and amido proton signals were detected between d 8.06-9.52. The 13 C-NMR spectrum showed 48 signals that were assigned to eight methyl, 15 methine, and 25 quaternary carbons by heteronuclear multiple quantum coherence and distortionless enhancement by polarization transfer experiments ( Table 2) . The C-H connectivity and assignment of the signals were confirmed by 2D NMR experiments using 1 H-1 H COSY and heteronuclear multiple bond coherence (HMBC) techniques as follows:
Thiazole units
The thiazole units were contained in substructures B, C and D (Figure 2 ), and the whole structure was deduced by comparison with those of the corresponding 1 H and 13 C chemical shifts with those reported for promoinducin, 9 nocathiacins 10 and radamycin. 11 As a result, six thiazole units were determined by the following longrange correlations; in the HMBC spectrum, the thiazole ring proton signal at d 8.43 (H-9) showed long-range couplings to carbons at Finally, each substructure was connected by the long-range correlations of the HMBC technique from the amide proton (H-6) to the carbonyl carbon (C-7), H-22 to C-28, H-32 to C-37, H-44 to C-45 and H-49 to C-50. Thus, the planar structure of nocardithiocin was determined as shown in Figure 1 and the 1 H and 13 C-NMR spectral data of nocardithiocin are summarized in Table 2 .
Stereochemistry
To determine the absolute configurations of substructures C and E, the advanced Marfy method 13,14 was performed. Nocardithiocin was first hydrolyzed with 6 M HCl and the liberated threonine (substructure E) and the valine-derived thiazole moiety (substructure C) were derivatized with 1-fluoro-2,4-dinitrophenyl-5-L-leucineamide (L-FDLA) and D-FDLA. Figure 3 shows the HPLC chromatograms of the 2,4-dinitrophenyl-5-L-leucineamide (DLA) derivatives ((A) with L-FDLA and (B) with D-FDLA) of the hydrolyzate. Two desired peaks were observed together with large amounts of the residual reagent and related compounds (*). Furthermore, an intense peak was also found at around 4 min. These derivatives were also analyzed by LC/MS at m/ z 414 and 459 in the positive ion mode (Figure 4) . 15 Using the DL-FDLA method, 16 it was possible to conclude that the two amino acids have the L configuration. It was also found that the intense peak observed at around 4 min shown in Figure 3 has a molecular weight of 616. The geometries of the double bonds in substructures A and D and the absolute configuration of substructure B could not be determined in this study.
Antimicrobial activity
Nocardithiocin showed a strong antimicrobial activity against acidfast bacteria but its activity against other Gram-positive microorganisms was moderate. The MIC values of the antibiotic against Corynebacterium xerosis and Gordonia bronchialis were o0.0078 and 0.039 mg ml À1 , respectively ( Table 3 ). As shown in Table 4 , nocardithiocin showed a strong antimicrobial activity against the rifampicin-resistant strains of M. tuberculosis as well as the susceptible ones, and their MIC values were 0.025-6.25 mg ml À1 and 0.025-46.25 mg ml À1 , respectively. In the comparison of the antimicrobial activity of nocardithiocin with the reference drug of levofloxacin against rifampicin-susceptible as well as rifampicin-resistant mycobacteria, nocardithiocin was found to show an activity higher than that of levofloxacin. Nocardithiocin did not show any antimicrobial activities against gram-negative bacteria and fungi (Table 3) . The cytotoxicity of nocardithiocin against LH-60 was 64 mg ml À1 (data not shown). Nocardithiocin, a novel thiopeptide antibiotic A Mukai et al DISCUSSION During our continuing studies of biologically active compounds from pathogenic actinomycetes, we have isolated many biologically active compounds from the Nocardia species. According to a review by Bagley et al., 6 the first thiopeptides produced by the Nocardia species to be identified were the nocathiacins, which belonged to series e because they possessed a tetrasubstituted hydroxypyridine as the central heterocyclic domain. In this study, Nocardia pseudobrasiliensis (IFM 0757) obtained from a patient at the Health Center, University of Texas, was studied. The strain produced several active compounds, of which nocardicyclin A was characterized as a broth metabolite 17 and nocardithiocin as a metabolite associated with the mycelium. 
Nocardithiocin, a novel thiopeptide antibiotic A Mukai et al
The latter structurally belongs to the thiopeptide group of antibiotics and was classified into series d, because it has a 2,3,6-trisubstituted pyridine domain as shown in Figure 1 . The identification of nocardithiocin was the second example of a thiopeptide from a Nocardia species. Nocardithiocin has a very similar thiopeptide nucleus to micrococcins P1 and P2 but differs in having a side chain terminating in an O-methyl moiety (substructure A) and subtle differences to the thiopeptide ring substructures termed substructures B and D. 6 Although the absolute configurations of C-32, -46 and -47 were firmly determined to be S, S and R, respectively, by advanced Marfey's method, those of C-23 and C-24 still remained unsolved. As mentioned above, the compound was slightly sensitive to light and the cause of this instability is currently under investigation. During our screening program of antimicrobial compounds, we have found and reported a new anthracycline type antibiotic called nocardicyclin. The structures were characterized by 1-and 8-methyl groups, a 10-carbonyl group and novel carbon-methylated amino sugar constituent. 17 Although the antibiotics exerted a cytotoxic activity against leukemia in mice, they showed anti-Gram-positive bacteria, especially a strong antimycobacterial activity. We also reported a new siderophore and a benzonoid compound called asterobactin and nocaracins, respectively. 18, 19 Interestingly, both the siderophore and benzonoid compounds also showed strong antimycobacterial activity. These studies suggested to us that the Nocardia strains are useful sources for new antimycobacterial compounds. Indeed, this study showed that a pathogenic Nocardia strain produced a unique antibiotic, nocardithiocin. Although the reason for higher productivity of the antimycobacterial substances in Nocardia strains is not clear, it may be because of the high similarity of Nocardia to Mycobacterium strains regarding their physiological characteristics such as cell membrane or cell wall permeability. Both genera belong to a special bacterial group of acid-fast bacteria.
METHODS Instrumentation
The NMR experiments were performed using JEOL-A400, -EXP-500 and -A600 spectrometers (Tokyo, Japan) in DMSO-d 6 Nocardithiocin, a novel thiopeptide antibiotic A Mukai et al conditions. The UV spectra were recorded on a Shimadzu UV-2100 (Kyoto, Japan). The optical rotations were measured by a Jasco DIP-370 polarimeter (Tokyo, Japan). HPLC was carried out using the following two systems: pump; Shimadzu LC-9A, detector, Shimadzu SPD-10A (UV-VIS) or Shimadzu SPD-M10A (diode array) and pump; TOSOH CCPS, detector; TOSOH UV-8020 (Tokyo, Japan).
Fermentation
The seed broth was prepared by inoculating mycelial elements of Nocardia pseudobrasiliensis IFM 0757 grown on the Brain Heart Infusion broth (BHI: Difco Laboratories, Detroit, MI, USA) in 10 ml with 2% glucose in a 50 ml Erlenmeyer shake flask. The culture was incubated on a rotary shaker at 250 r.p.m. for 4 days. Ten percent of the inoculum was transferred to a 500 ml Erlenmeyer shake flask containing 100 ml of the production medium (two times concentrated nutrient broth medium, Difco Laboratories) and the culture was incubated on a rotary shaker at 250 r.p.m. for 7 days.
Isolation
After centrifugation of the culture broth (2 l), the mycelia were subjected to extraction by MeOH with stirring. The extract was evaporated and the residue was subjected to liquid-liquid extraction with EtOAc and water. The EtOAc fraction was evaporated and the residue was separated by the following HPLC procedure under dark conditions to provide nocardithiocin in a pure state (10.5 mg): column, Cosmosil 5C18-ARII (250Â10 mm ID, Nacalai Tesque, Kyoto, Japan); mobile phase, MeOH: 0.01% TFA¼52:48; flow rate, 1.0 ml min À1 ; detection; 254 nm.
Advanced Marfey's method
One milligram of nocardithiocin was dissolved in 500 ml of 6 M HCl, and then heated at 110 1C for 1 h under nitrogen. The reaction solution was evaporated to dryness and 150 ml of water and 50 ml of MeOH were added. The solution was divided into two portions and 20 ml of 1 M NaHCO 3 and 100 ml of 1% 
Antimicrobial activity measurement
The antimicrobial activities were determined by a method described earlier 20 using the microbroth dilution method, except for the determination of MIC values against the slowly growing mycobacteria. The antimicrobial activities against the slowly growing mycobacteria were determined by the agar dilution method using the MIDDLEBROOK 7H10 agar medium (BD, Difco). Inocula were prepared by incubation of the Mycobacterium species in MIDDLEBROOK (7H9) liquid medium at 37 1C for 2-3 weeks in a 5% CO 2 incubator. After adjustment of the cell concentration by the optical density measurement, the diluted cell suspensions were inoculated onto the MIDDLEBROOK 7H10 agar medium containing various drug concentrations. After incubation at 37 1C for 14 days (for Mycobacterium avium and Mycobacterium intracellulare) and 21 days (for M. tuberculosis), the MIC values were determined. The M. tuberculosis H37Rv strain was used as the standard strain. Rifampicin (REF; Sigma-Aldrich Co., Tokyo, Japan) and levofloxacin (Daiichi Seiyaku Co., Tokyo, Japan) were used as the reference drugs in this study. 
